Skip to main content

Table 3 Association between maternal hyperuricemia and different pregnancy outcome characteristics

From: Maternal hyperuricemia in normotensive singleton pregnancy, a prenatal finding with continuous perinatal and postnatal effects, a prospective cohort study

Characteristic

Maternal hyperuricemia

Unadjusted OR (95% CI)

Adjusted OR † (95% CI)

Yes

No

N (%)

N (%)

SGA

14 (13.5)

32 (10.6)*

1.34 (1.12 – 2.63)

1.28 (1.04 – 2.57)

The need for resuscitation

10 (9.7)

17 (5.6)

1.77 (0.78 – 4.01)

1.27 (0.53 – 3.06)

Low 1-minute APGAR

18 (17.4)

22 (7.3)*

2.64 (1.35 – 5.16)

1.93 (0.94 – 3.99)

Low 5-minute APGAR

18 (17.4)

22 (7.3)*

2.64 (1.35 – 5.16)

1.93 (0.94 – 3.99)

NICU admission

31 (30)

48 (15.9)*

2.26 (1.34 – 3.82)

1.65 (1.12 – 2.94)

Neonatal hyperglycemia

1/31 (3.22)

5/48 (10.4)

0.56 (0.31 – 10.26)

0.32 (0.23 – 7.5)

Neonatal hypoglycemia

10/31 (32.2)

8/48 (16.6)*

3.48 (1.37 – 8.84)

2.45 (0.9 – 6.66)

Neonatal hyperbilirubinemia

7/31 (22.5)

14/48 (29.1)

0.64 (0.27 – 1.48)

0.21 (0.08 – 2.40)

Neonatal RDS

8 (7.76)

8 (2.65)

1.99 (0.88 – 5.07)

1.79 (0.43 – 4.06)

Neonatal IVH

6 (5.8)

1 (0.3)*

12.01 (1.44 – 101.32)

8.14 (1.11 – 87.1)

Neonatal mortality

3 (2.91)

0 (0)

-

-

  1. OR: odds ratio, 95% CI: 95% confidence interval, †: adjusted for gestational age and birth weight, neonatal hypoglycemia was additionally adjusted for maternal diabetes, *: P < 0.05 for the comparison between two groups with and without the specified characteristic, SGA: small for gestational age delivery, APGAR: Apgar score, RDS: respiratory distress syndrome, IVH: intraventricular hemorrhage.